BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10342679)

  • 21. Conization as treatment of carcinoma in situ of the uterine cervix.
    Ahlgren M; Ingemarsson I; Lindberg LG; Nordqvist RB
    Obstet Gynecol; 1975 Aug; 46(2):135-9. PubMed ID: 1153146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conization non in sano].
    Lahousen M; Pickel H; Girardi F; Jäger G
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():131. PubMed ID: 1286317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of carcinoma in situ of the cervix.
    Sprang ML; Isaacs JH; Boraca CT
    Am J Obstet Gynecol; 1977 Sep; 129(1):47-50. PubMed ID: 900168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical adenocarcinoma in situ.
    Hopkins MP; Roberts JA; Schmidt RW
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):842-4. PubMed ID: 3285263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer Registry.
    Pettersson F; Malker B
    Radiother Oncol; 1989 Oct; 16(2):115-20. PubMed ID: 2595011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of carcinoma in situ. II. Evaluation by conization. Treatment after incomplete conization. Treatment by complete conization as only therapy. Conclusions (author's transl)].
    Holzer E
    Arch Gynecol; 1979 Sep; 227(3):225-47. PubMed ID: 496439
    [No Abstract]   [Full Text] [Related]  

  • 33. [The diagnosis, management and treatment results in patients with carcinoma in situ of the cervix uteri].
    Chakalova G; Karag'ozov A; Ganchev G; Kŭrlov T; Popova M; Ralcheva Ts
    Akush Ginekol (Sofiia); 1990; 29(4):48-51. PubMed ID: 2267981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of carcinoma in situ of the uterine cervix in the Mersey Regional Cancer Registry Area with some comments on incidence.
    Freedman LS; Edwards DN
    Clin Radiol; 1978 Nov; 29(6):593-8. PubMed ID: 737948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005.
    Surie D; Dunne EF; Naleway AL; Weinmann S; Klein NP; Baxter R; Hutchins K; Gee J; Markowitz L
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1129-32. PubMed ID: 23563889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
    Strander B; Hällgren J; Sparén P
    BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of carcinoma in situ. I. Material. Primary treatment. Treatment after evaluation by ringbiopsy (author's transl)].
    Holzer E
    Arch Gynecol; 1979 Sep; 227(3):205-24. PubMed ID: 496438
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation between cervical intraepithelial neoplasia and invasive cervical carcinoma on the basis of their frequency in the Province of Trieste (1977-1986).
    Di Bonito L; Delendi M; Patriarca S; Quaranta M; Alberico S; Facca MC
    Eur J Gynaecol Oncol; 1989; 10(2):147-52. PubMed ID: 2721523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal hysterectomy following conization in the treatment of carcinoma in situ of the cervix.
    Van Nagell JR; Roddick JW; Cooper RM; Triplett HB
    Am J Obstet Gynecol; 1972 Aug; 113(7):948-51. PubMed ID: 4564441
    [No Abstract]   [Full Text] [Related]  

  • 40. Selected demographic characteristics of Israeli Jewish women with high-grade cervical intraepithelial neoplasia (CIN3): a population-based study.
    Kogan L; Menczer J; Shejter E; Liphshitz I; Barchana M
    Arch Gynecol Obstet; 2011 Feb; 283(2):329-33. PubMed ID: 20191281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.